Medications

FDA approves new drug to protect against RSV in infants

Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.

Oncology & Cancer

Cancer patients face greater risks from abdominal aneurysm repair

Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes according to a newly published study from researchers at the University of Missouri ...

Diseases, Conditions, Syndromes

COVID-19 cases and hospitalizations surge among children

It's a tough time to be a parent. And it has been for nearly two years. Schools are threatening to close again (or already have) due to high COVID-19 volume. And pediatric case rates and hospitalizations are soaring—particularly ...

page 23 from 40